Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q99697
UPID:
PITX2_HUMAN
Alternative names:
ALL1-responsive protein ARP1; Homeobox protein PITX2; Paired-like homeodomain transcription factor 2; RIEG bicoid-related homeobox transcription factor; Solurshin
Alternative UPACC:
Q99697; A8K6C6; B2RA02; B3KXS0; O60578; O60579; O60580; Q3KQX9; Q9BY17
Background:
Pituitary homeobox 2 (Pitx2) is a pivotal transcription factor, known by various names such as Homeobox protein PITX2 and RIEG bicoid-related homeobox transcription factor. It plays a crucial role in cell proliferation, morphogenesis, and the embryonic development of asymmetric organs. Its involvement in muscle progenitor expansion and the establishment of left-right asymmetry highlights its significance in developmental biology.
Therapeutic significance:
Pitx2's association with diseases like Axenfeld-Rieger syndrome 1, Anterior segment dysgenesis 4, and Ring dermoid of cornea underscores its clinical importance. These conditions, characterized by eye development abnormalities leading to vision impairment, spotlight Pitx2 as a target for therapeutic intervention. Understanding Pitx2's role could pave the way for novel treatments for these ocular disorders.